A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell Interventions: Drug: Spartalizumab; Drug: Canakinumab Sponsors: Charles G. Drake; Novartis Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials